Masimo alleged Apple used its IP to fix problems with the sensors in Apple Watches. It claimed Apple recruited key experts from Masimo and a spin-off company. Apple asked the court to limit any award ...

A federal jury in California has found that Apple infringed on a Masimo patent for its pulse oximetry technology and awarded Masimo $634 million in damages, Masimo said Friday. “This is a significant ...

A FEDERAL jury in California said on Friday(Nov 14) that Apple owes medical-monitoring technology company Masimo US$634 million for infringing a patent covering blood-oxygen reading technology. The ...

A federal jury in California ruled Friday that Apple must pay medical monitoring technology company Masimo $634 million for infringing patents related to blood oxygen reading capabilities in its ...

Apple’s brush-up with Masimo a company that manufactures patient monitoring devices, over a patent lawsuit may not be over yet. 9to5Mac reports that, in new filings today, the ITC said it “has ...

Spring Training is a 2yo chestnut filly (female) from United States trained by Kevin C. Boniface, who is based at . She is sired by the stallion Kobe's Back out of the dam Sommer Something. Spring ...

This additional agreement will allow the sheriff's office to be reimbursed for costs incurred for training, mileage, equipment and overtime. Kansas mayor hit with criminal charges for allegedly voting ...

Masimo tightened its full-year 2025 revenue guidance to $1.510 billion to $1.530 billion, citing a $5 million adjustment at both the top and bottom ends. The company raised its operating margin ...

Revenue Growth: 8% increase in the third quarter. Operating Margin Expansion: 450 basis points increase year-over-year. Adjusted Earnings Per Share (EPS): Increased by 38% year-over-year to $1.32.

Good afternoon, ladies and gentlemen, and welcome to the Masimo Third Quarter 2025 Earnings Conference Call. The company's press release is available at www.masimo.com. Thank you. Hello, everyone.

Masimo Corporation (NASDAQ:MASI) released its third-quarter 2025 earnings presentation on November 4, showcasing solid financial performance despite new tariff challenges. The medical technology ...